Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial
- 1 February 2014
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 14 (2) , 109-118
Abstract
No abstract availableKeywords
Funding Information
- Centers for Disease Control and Prevention, Atlanta, GA, USA (1U01P000127)
This publication has 24 references indexed in Scilit:
- Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09Clinical Infectious Diseases, 2012
- Early Oseltamivir Treatment of Influenza in Children 1–3 Years of Age: A Randomized Controlled TrialClinical Infectious Diseases, 2010
- Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition AssaysAntimicrobial Agents and Chemotherapy, 2010
- Outcomes of adults hospitalised with severe influenzaThorax, 2010
- Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, CanadaClinical Infectious Diseases, 2007
- Duration of Influenza A Virus Shedding in Hospitalized Patients and Implications for Infection ControlInfection Control & Hospital Epidemiology, 2007
- Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with OseltamivirThe Journal of Infectious Diseases, 2001
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus InfectionsThe Journal of Infectious Diseases, 1999
- Patterns of Shedding of Myxoviruses and Paramyxoviruses in ChildrenThe Journal of Infectious Diseases, 1981
- Viral Shedding Patterns of Children with Influenza B InfectionThe Journal of Infectious Diseases, 1979